3 months to expiry Ghana · FDA Ghana

ALBENCARE TABLETS 2500MG

ALBENAZOLE

FDA/V.223-06031 ALBENAZOLE 2500MG

What it does

Albendazole is a medicine used to treat infections caused by certain types of worms.

Commonly used for: worm infections (helminthiasis), neurocysticercosis, hydatid disease

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/V.223-06031
Registration date
2022-06-29
Expiry date
2027-01-07
Status
3 months to expiry
Active ingredient
ALBENAZOLE
Dosage form
ALBENAZOLE
Strength
2500MG
Pack size
-
Therapeutic class
-
Country of origin
CHINA

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:09 · updated 2026-10-20 04:00:03

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Albendazole is a medicine used to treat infections caused by certain types of worms.

What it treats

  • worm infections (helminthiasis)
  • neurocysticercosis
  • hydatid disease

How it works

Albendazole works by killing the worms and preventing them from growing and multiplying in the body.

Who it's for

This medication is for people diagnosed with specific parasitic worm infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: albenazole

Albendazole is an anthelmintic medication commonly used to treat various parasitic worm infections. It belongs to the benzimidazole class of drugs and is effective against a broad spectrum of helminths, including nematodes and cestodes. Its use is particularly important in the management of conditions such as neurocysticercosis and hydatid disease.

Indications

  • Neurocysticercosis
  • Hydatid disease
  • Ascariasis
  • Enterobiasis (pinworm infection)
  • Trichuriasis
  • Hookworm infections
  • Strongyloidiasis
  • Taeniasis

Dosage

Children: Refer to BNF for Children for specific dosing information as it varies based on the condition being treated.

Adults: Refer to BNF for specific dosing information as it varies based on the condition being treated.

Mechanism of action

Albendazole exerts its anthelmintic effects primarily by inhibiting the polymerization of tubulin into microtubules, which disrupts the cytoplasmic transport and leads to the depletion of glucose and other essential metabolites in the parasites. This ultimately results in their death.

Pharmacodynamics

The drug displays a concentration-dependent activity against a variety of parasitic worms. Albendazole is effective in inhibiting the growth and reproduction of helminths, leading to their elimination from the host. Resistance may develop in some parasites, particularly with prolonged use.

Pharmacokinetics

Albendazole is poorly absorbed from the gastrointestinal tract; however, it is rapidly metabolized in the liver to its active metabolite, albendazole sulfoxide. The bioavailability can be significantly enhanced when administered with fatty meals. The drug has a volume of distribution of approximately 100 L, and its elimination half-life is around 8 to 12 hours. It is excreted primarily in urine as metabolites.

Contra-indications

  • Hypersensitivity to albendazole or any excipients
  • Pregnancy (especially in the first trimester)

Adverse effects

  • Abdominal pain
  • Nausea
  • Vomiting
  • Headache
  • Dizziness
  • Liver enzyme elevation
  • Alopecia

Interactions

  • Cimetidine may increase plasma concentrations of albendazole
  • Drugs that affect liver enzymes (e.g., phenytoin, carbamazepine) may decrease albendazole levels

Precautions

  • Monitor liver function tests during treatment
  • Use caution in patients with liver disease
  • Not recommended for use in children under 2 years of age unless directed by a physician

Pregnancy

Albendazole is contraindicated in pregnancy due to potential teratogenic effects.

Breast-feeding

Use caution when administering to breastfeeding mothers; the drug is excreted in breast milk.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Albendazole 400 mg tablet
  • Albendazole suspension (e.g., 100 mg/5 ml)

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.